FMR LLC 13D and 13G filings for Ikena Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-03-11 08:19 am Sale | 2024-03-08 | 13G | Ikena Oncology, Inc. IKNA | FMR LLC | 101,250 2.771% | -247,441 (-70.96%) | Filing |
| 2024-02-09 09:16 am Purchase | 2024-02-08 | 13G | Ikena Oncology, Inc. IKNA | FMR LLC | 348,691 9.545% | 38,310 (+12.34%) | Filing |
| 2023-01-10 12:48 pm Purchase | 2023-01-09 | 13G | Ikena Oncology, Inc. IKNA | FMR LLC | 310,381 10.272% | 99,864 (+47.44%) | Filing |
| 2022-10-11 09:03 am Sale | 2022-10-07 | 13G | Ikena Oncology, Inc. IKNA | FMR LLC | 210,517 6.967% | -183,124 (-46.52%) | Filing |
| 2022-02-09 09:19 am Purchase | 2022-02-08 | 13G | Ikena Oncology, Inc. IKNA | FMR LLC | 393,641 13.155% | 78,837 (+25.04%) | Filing |
| 2021-04-12 1:05 pm Purchase | 2021-04-09 | 13G | Ikena Oncology, Inc. IKNA | FMR LLC | 314,803 12.541% | 314,803 (New Position) | Filing |